ArticleProbiotics and antimicrobial proteins2026
Enterococcus Durans J396 Isolated from the Intestine of a Pig Enhances the Antioxidant Activity in Caenorhabditis Elegans.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Remodeling the gut microbiota: mechanistic insights into probiotic-mediated alleviation of weaning stress in piglets.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
Enterococcus durans is a potential probiotic with beneficial for the health of people and animals. However, the understanding of the antioxidant activity of E. durans is limited. In this study, the antioxidant activity of E. durans isolate J396 was investigated. The strain was well tolerant to heat stress and showed extensively resistant to acid and bile salts. In vitro, the DPPH radical scavenging ability of J396 was 89.95%. Feeding of Caenorhabditis elegans with J396 did not affect nematodes growth and reproduction, and significantly prolonged the lifespan of the nematodes. In addition, the superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-px), and total antioxidant capacity (T-AOC) activities increased by 57.05%, 36.25%, 82.88%, and 49.96%, respectively. The malondialdehyde (MDA), lipofuscin, and reactive oxygen species (ROS) levels were reduced by 28.40%, 28.72%, and 65.57%, respectively. E. durans J396 effectively protected C. elegans from hydrogen peroxide-induced oxidative stress damage. The activity of SOD, CAT, GSH-px, and T-AOC increased by 142.03%, 74.86%, 62.01%, and 94.16%, respectively. Feeding E. durans J396 to C. elegans decreased MDA, lipofuscin, and ROS by 33.59%, 19.70%, and 56.42%, respectively. RT-qPCR analysis showed that the feeding of C. elegans with J396 upregulated the expressions levels of nsy-1, pmk-1, skn-1, and sod-3 in C. elegans. Our study confirmed the antioxidant properties of E. durans J396, indicating its potential application in the pharmaceutical industry and the antioxidant therapy for animals.
Indexed as
Identifiers
40773038What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.